Karl Ljungberg
Karolinska Institutet Science Park
Solna, AB 17165, Sweden
Solna, AB 17165, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
DNA Vaccine Development at Pre- and Post-Operation Warp Speed.
Journal: Vaccines
Published: November 17, 2020
Infectious RNA vaccine protects mice against chikungunya virus infection.
Journal: Scientific reports
Published: August 12, 2020
Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe.
Journal: mSphere
Published: November 29, 2019
Seroreactivity to Chikungunya and West Nile Viruses in Rwandan Blood Donors.
Journal: Vector borne and zoonotic diseases (Larchmont, N.Y.)
Published: June 28, 2019
Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Journal: Journal of virology
Published: January 11, 2019
DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost.
Journal: Scientific reports
Published: March 23, 2018
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Journal: Journal of virology
Published: March 02, 2018
Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.
Journal: Human vaccines & immunotherapeutics
Published: July 12, 2017
Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
Journal: JCI insight
Published: March 30, 2017
HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.
Journal: Heliyon
Published: March 22, 2017
Last Updated: 09/26/2026